WebCurrently 13 wall-street analysts regularly analyze the financials of INOZYME PHARMA INC on a frequent basis to provide recommendations along with target share price. 13 … Web6 apr. 2024 · 247wallst.com - April 7 at 12:43 PM. Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) to Newly Appointed Chief Operations Officer. finance.yahoo.com - April 4 at 12:34 PM. Insider Buying: Inozyme Pharma, Inc. (NASDAQ:INZY) Director Buys $1,564,447.68 in Stock. americanbankingnews.com - …
INZY Institutional Ownership and Shareholders - Inozyme Pharma …
WebInozyme Pharma, Inc. Common Stock (INZY) ... The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for … WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … immatriculation vhl
Inozyme Pharma Inc. (NASDAQ: INZY) Rises 10.30% This Year: …
Web12 apr. 2024 · The trading price of Inozyme Pharma Inc. (NASDAQ:INZY) closed higher on Tuesday, April 11, closing at $5.89, 8.27% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $5.3121 and $6.00. In examining the 52-week price actio Web8 apr. 2024 · Management seems especially optimistic here with director Robert Hopfner acquiring over $2 million in INZY well over current market prices Inozyme went public during the summer of 2024 quickly rocketing to highs over $30 per share followed by several years of steady losses that culminated in INZY hitting all-time lows of $0.99 in December. Web6 apr. 2024 · A high-level overview of Inozyme Pharma, Inc. (INZY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … immature characters